James Taylor

James Taylor, Pharm.D., CDE, BCACP

Professor

Department: Pharmacy Education and Practice
Business Phone: (352) 273-6239
Business Email: jtaylor@cop.ufl.edu

About James Taylor

Hello, my name is Jim Taylor, and I am a clinical professor in the University of Florida Department of Pharmacy Education and Practice. I received my doctor of pharmacy degree from Ohio Northern University. Upon graduation, I completed an ASHP-accredited pharmacy practice residency at the Veterans Affairs Medical Center in Huntington, West Virginia, and then completed a family medicine residency at UF. After graduating pharmacy school, I spent two years completing additional residency training focused on ambulatory care. I am a certified diabetes educator and board-certified ambulatory care pharmacist.

After becoming interested in pursuing a career in health care, I spent time shadowing a pharmacist and really enjoyed the patient interactions and helping patients with their medications. I currently serve as the pharmacy director for the UF Health Shands Anticoagulation Clinic and director of the Professional Practice Skills Lab series for the UF College of Pharmacy. I coordinate the third-year lab courses and am responsible for oversight of the third- and fourth-year OSCEs.

In past years, I practiced in a family practice clinic and served as residency director for an ambulatory care residency. I have had an active role in the Laboratory Instructors SIG since 2016, serving as chair of the mentoring and networking committee for the past three years. I have presented at the AACP Annual Meeting on Lab SIG topics and lead Lab SIG webinars. I have given numerous other professional presentations on diabetes, anticoagulation and other primary care topics, and I have published extensively on primary care and educational topics such as OSCEs. Finally, I have served as principal investigator and co-principal investigator for a number of clinical trials.

In addition to clinical practice, I spend a significant amount of time educating pharmacy students in the classroom and in clinical environments. My current research interests include assessing APPE readiness and anticoagulation. I have over 20 years of experience managing chronic mediations and am currently focused on managing all the patients on anticoagulant therapies.

I am married with two children. When I’m not working, you can find me exercising, playing golf or spending time with my family.

Teaching Profile

Courses Taught
2017-2023
PHA5165L Prof Skills Lab V
2018-2025
PHA5166L Prof Skills Lab Vi
2018,2020-2021
PHA5519 Advanced Topics in Anticoagulation Pharmacotherapy
2018
PHA5763 Ambulatory Care Advanced Pharmacy Practice Experience
2018
PHA5060 Ambulatory Care
2017-2018
PHA5787C Pt Care 5: Endo
2008-2016
PHA5108L Pharmaceu Skls Lab 1
2011,2013-2015
PHA6634 Medication Therapy Management: An Endocrine Focus
2011-2015
PHA5782 Pharmacotherapy 2
2012-2015
PHA5787 Pharmacotherapy 5
2006-2010
PHA5895 Intr Clin Tch in Acad
2006-2008
PHA5783 Pharmacotherapy 3

Clinical Profile

Specialties
  • Pharmacy

Research Profile

Comparison of point of care HbA1c monitor versus standard laboratory, Community Health Center at Eastside

Health Literacy Awareness, Community Health Center at Eastside

Clinical Pharmacy PAD Awareness Outreach Program, Community Health Center at Eastside. (grant received in amount of $4500)

Comparison of point of care HbA1c monitor versus standard laboratory, Community Health Center at Eastside

Publications

2024
Implementation of standard setting for high-stakes objective structured clinical examinations
Currents in Pharmacy Teaching and Learning. 16(6):465-468 [DOI] 10.1016/j.cptl.2024.03.008.
2024
Use of Dulaglutide, Semaglutide, and Tirzepatide in Diabetes and Weight Management
Clinical Therapeutics. 46(3):289-292 [DOI] 10.1016/j.clinthera.2023.12.014.
2023
Implementation of a series of advanced pharmacy practice experience (APPE) preparatory topics into a skills lab curriculum
Currents in Pharmacy Teaching and Learning. 15(2):218-223 [DOI] 10.1016/j.cptl.2023.02.029.
2022
Implementing interactive hiring activity in pharmacy management education
Currents in Pharmacy Teaching and Learning. 14(2):208-214 [DOI] 10.1016/j.cptl.2021.11.010.
2021
Protecting the Integrity of the Virtual Objective Structured Clinical Examination.
American journal of pharmaceutical education. 85(6) [DOI] 10.5688/ajpe8438. [PMID] 34315707.
2021
Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease.
American journal of nephrology. 52(7):582-587 [DOI] 10.1159/000517056. [PMID] 34375971.
2020
Ambulatory care elective: Introduction to core practice concepts.
Currents in pharmacy teaching & learning. 12(3):331-338 [DOI] 10.1016/j.cptl.2019.12.013. [PMID] 32273072.
2020
Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
British journal of haematology. 190(1):e45-e48 [DOI] 10.1111/bjh.16702. [PMID] 32372411.
2020
Oral Semaglutide: The First-available Noninjectable Glucagon-like Peptide 1 Receptor Agonist.
Clinical therapeutics. 42(10):2100-2116 [DOI] 10.1016/j.clinthera.2020.07.017. [PMID] 32873415.
2020
Recommendations for integration of foundational and clinical sciences throughout the pharmacy curriculum.
Currents in pharmacy teaching & learning. 12(11):1371-1374 [DOI] 10.1016/j.cptl.2020.06.006. [PMID] 32867937.
2020
Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.
American journal of hematology. 95(7):766-774 [DOI] 10.1002/ajh.25799. [PMID] 32243618.
2017
Prostacyclin-analog therapy in sickle cell pulmonary hypertension.
Haematologica. 102(5):e163-e165 [DOI] 10.3324/haematol.2015.131227. [PMID] 28126964.
2016
Clinical Validation of R-T Estimation for Coaguchek Xs Inr Results
Annals of Pharmacotherapy. 50(8):645-648 [DOI] 10.1177/1060028016647975.
2016
Correction of Point-of-Care INR Results in Warfarin Patients.
Point of care. 15(1):1-3 [PMID] 27103879.
2016
Patient Satisfaction With Extended-Interval Warfarin Monitoring
Journal of Thrombosis and Thrombolysis. 42(4):486-493 [DOI] 10.1007/s11239-016-1385-9.
2015
Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists.
Clinical therapeutics. 37(3):483-93 [DOI] 10.1016/j.clinthera.2015.01.003. [PMID] 25659912.
2015
Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.
Cardiovascular therapeutics. 33(3):98-103 [DOI] 10.1111/1755-5922.12115. [PMID] 25786578.
2015
Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.
PloS one. 10(11) [DOI] 10.1371/journal.pone.0141706. [PMID] 26576059.
2014
Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
European journal of haematology. 92(4):341-5 [DOI] 10.1111/ejh.12245. [PMID] 24330217.
2014
Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations.
Drugs. 74(18):2141-52 [DOI] 10.1007/s40265-014-0325-2. [PMID] 25414121.
2013
Canagliflozin: a novel treatment option for type 2 diabetes.
Drug design, development and therapy. 7:1399-408 [DOI] 10.2147/DDDT.S48937. [PMID] 24285921.
2013
Insulin analogs for the management of type 2 diabetes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 70(4):320-34 [DOI] 10.2146/ajhp110381. [PMID] 23370139.
2013
Lorcaserin for weight management.
Diabetes, metabolic syndrome and obesity : targets and therapy. 6:209-16 [DOI] 10.2147/DMSO.S36276. [PMID] 23788837.
2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
Clinical therapeutics. 35(1):A3-17 [DOI] 10.1016/j.clinthera.2012.12.012. [PMID] 23328274.
2012
Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.
The Journal of pediatrics. 160(2):286-90 [DOI] 10.1016/j.jpeds.2011.07.018. [PMID] 21890147.
2012
Teaching clinical problem solving: a preceptor’s guide.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 69(18):1588-99 [DOI] 10.2146/ajhp110521. [PMID] 22935942.
2011
Cranberry phytochemicals inhibit glycation of human hemoglobin and serum albumin by scavenging reactive carbonyls.
Food & function. 2(8):475-82 [DOI] 10.1039/c1fo10087d. [PMID] 21826359.
2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
Circulation. 124(13):1452-60 [DOI] 10.1161/CIRCULATIONAHA.111.032920. [PMID] 21900080.
2011
Recent diabetes issues affecting the primary care clinician.
Southern medical journal. 104(6):456-61 [DOI] 10.1097/SMJ.0b013e318213e92b. [PMID] 21886036.
2011
Successful Reorganization of An Interdisciplinary Underserved Practice
Journal of Health Care for the Poor and Underserved. 22:226-231
2010
A New Glucose Monitoring Option
Journal of Family Practice. 59:81-88
2008
Dpp-Iv Inhibitors: a Review of Sitagliptin, Vildagliptin, Alogliptin, and Saxagliptin
Formulary. 43
2007
Diabetes drug update: how 4 new options stack up.
The Journal of family practice. 56(3):207-15 [PMID] 17343811.
2007
Home monitoring of glucose and blood pressure.
American family physician. 76(2):255-60 [PMID] 17695570.
2006
Pharmacologic management of chronic insomnia.
Southern medical journal. 99(12):1373-7 [PMID] 17233194.
2006
Probable interaction between tolterodine and warfarin.
Pharmacotherapy. 26(5):719-21 [PMID] 16718947.

Grants

Jul 2014 – Jul 2017
Accuracy of CoaguChek XS in Patients with Antiphospholipid Antibody Syndrome
Role: Principal Investigator
Funding: ROCHE DIAGNOSTICS CORP

Education

Board Certified Ambulatory Care Pharmacist
2015 · Board of Pharmacy Specialties
Pharm.D.
1996 · Ohio Northern University

Contact Details

Phones:
Business:
(352) 273-6239
Emails:
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610
Business Street:
101 SOUTH NEWELL DR, HPNP RM 3313
GAINESVILLE FL 32611